PTGX 股票新闻 — 实时报道

PTGX 最新新闻

PTGX 的最新新闻报道，汇总自华尔街日报、彭博、纽约时报、金融时报与 Google 新闻，实时更新，免费无广告。标题保留原文。

1. Here's How Much $100 Invested In Protagonist Therapeutics 10 Years Ago Would Be Worth TodayBenzinga · 2026-09-28
2. Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC FilingYahoo Finance · 2026-09-11
3. Protagonist Therapeutics at Cantor conference: cash, launches and pipelineInvesting.com · 2026-09-10
4. Protagonist Therapeutics Announces $300 Million Share Repurchase ProgramYahoo Finance · 2026-09-08
5. Protagonist (PTGX) Swings To A Profit As Two Drugs Near Blockbuster StatusYahoo Finance · 2026-09-06
6. MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?Yahoo Finance · 2026-09-04
7. Protagonist Therapeutics stock rating maintained at Buy by Clear StreetInvesting.com · 2026-08-31
8. Jefferies reiterates Protagonist Therapeutics stock rating on Mimrylo label strengthInvesting.com · 2026-08-31
9. Wolfe Research reiterates Protagonist Therapeutics stock rating at outperform By Investing.comInvesting.com · 2026-08-31
10. Wolfe Research reiterates Protagonist Therapeutics stock rating at outperformInvesting.com · 2026-08-31
11. Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera - Slideshow (NASDAQ:PTGX) 2026-08-31Seeking Alpha · 2026-08-31
12. J&J granted China nod for oral psoriasis pill developed with ProtagonistSeeking Alpha · 2026-08-28
13. Protagonist Therapeutics CEO Dinesh Patel sells $14.9m in stockInvesting.com · 2026-08-12
14. Protagonist Therapeutics: 'Strong Buy' ICOTYDE FDA Approval And PN-881 Advancement (PTGX)Seeking Alpha · 2026-08-12
15. Surging Earnings Estimates Signal Upside for Protagonist Therapeutics (PTGX) StockYahoo Finance · 2026-08-07

PTGX 期权：最大痛点、Gamma 敞口（GEX）与关键价位 · 在新闻存档中搜索 PTGX · 全部股票